Horobin Joanna
- SEC CIK
- 0001560959
No open-market purchases or sales filed in the past year.
Current role at each company
- LQDA Liquidia CorpDirectoras of Jun 18, 2026
- KYMR Kymera Therapeutics, Inc.Directoras of Jun 7, 2024
- VYNT Vyant Bio, Inc.Directoras of Jan 19, 2023
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Horobin Joanna as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
LQDA Liquidia Corp
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 21, 2025 (view filing) | Aug 19 | 2 days | Horobin JoannaDirector | SSale | −5.00K | $27.17 | −$135.8K | −12.9%33.8K after |
KYMR Kymera Therapeutics, Inc.
Director1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 7, 2024 (view filing) | Jun 7 | Same day | Horobin JoannaDirector | SSale | −8.50K | $32.99 | −$280.4K | −100.0%0 after | 2 lots10b5-1 |